Estimating Costs Associated with Disease Model States Using Generalized Linear Models: A Tutorial.
Zhou J. et al, (2024), Pharmacoeconomics, 42, 261 - 273
Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling study
MIHAYLOVA B. et al, (2024), The Lancet Regional Health - Europe
Long-term cardiovascular risks and statin treatment impact on socioeconomic inequalities: microsimulation model
Wu R. et al, (2023), British Journal of General Practice
Impact of new cardiovascular events on quality of life and hospital costs in people with cardiovascular disease in the UK and US
MIHAYLOVA B. et al, (2023), Journal of the American Heart Association
Prediction models for individual-level healthcare costs associated with cardiovascular events in the UK
Zhou J. et al, (2022), PharmacoEconomics
Modelling decay in effectiveness for evaluation of behaviour change interventions: a tutorial for public health economists.
Candio P. et al, (2022), Eur J Health Econ, 23, 1151 - 1157
Estimating and Extrapolating Survival Using a State-Transition Modeling Approach: A Practical Application in Multiple Myeloma.
Majer I. et al, (2022), Value Health, 25, 595 - 604
Benefit accrual with cardiovascular disease prevention and effects of discontinuation: a modelling study
Wu R. et al, (2022), EUROPEAN HEART JOURNAL, 43, 2850 - 2850
CALIBRATING CARDIOVASCULAR DISEASE POLICY MODEL USING LARGE COHORT DATA
Wu R. et al, (2022), VALUE IN HEALTH, 25, S16 - S16
Cost-effectiveness of statin therapy in categories of patients in the UK
Mihaylova B. et al, (2022), EUROPEAN HEART JOURNAL, 43, 2841 - 2841
EXCESS ANNUAL HOSPITAL COSTS DUE TO CARDIOVASCULAR EVENTS IN A CONTEMPORARY UK POPULATION TO INFORM HEALTH TECHNOLOGY ASSESSMENTS
Zhou J. et al, (2022), VALUE IN HEALTH, 25, S12 - S12
Impact of cardiovascular events on primary and hospital care costs: findings from UK Biobank study
Zhou J. et al, (2022), EUROPEAN HEART JOURNAL, 43, 2852 - 2852
P55 Excess Annual Hospital Costs Due to Cardiovascular Events in a Contemporary UK Population to Inform Health Technology Assessments
Zhou J. et al, (2022), Value in Health, 25, S12 - S12
P70 Calibrating Cardiovascular Disease Policy Model Using Large Cohort Data
Wu R. et al, (2022), Value in Health, 25, S16 - S16
A model of lifetime health outcomes in cardiovascular disease based on clinical trials and large cohorts
Wu R. et al, (2021), EUROPEAN HEART JOURNAL, 42, 3149 - 3149
Impact of adverse events on quality of life and hospital costs in secondary cardiovascular disease prevention
Lui NMJ. et al, (2021), EUROPEAN HEART JOURNAL, 42, 3159 - 3159
Cost-effectiveness Analysis in R Using a Multi-state Modeling Survival Analysis Framework: A Tutorial.
Williams C. et al, (2017), Med Decis Making, 37, 340 - 352
Estimation of Survival Probabilities for Use in Cost-effectiveness Analyses: A Comparison of a Multi-state Modeling Survival Analysis Approach with Partitioned Survival and Markov Decision-Analytic Modeling.
Williams C. et al, (2017), Med Decis Making, 37, 427 - 439
Endovascular aneurysm repair: is imaging surveillance robust, and does it influence long-term mortality?
Waduud MA. et al, (2015), Cardiovasc Intervent Radiol, 38, 33 - 39
Comorbidity and Intensive Care Outcome — A Multivariable Analysis
Docking R. et al, (2014), Journal of the Intensive Care Society, 15, 205 - 212